A detailed history of Raymond James & Associates transactions in Pfizer Inc stock. As of the latest transaction made, Raymond James & Associates holds 8,209,415 shares of PFE stock, worth $225 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
8,209,415
Previous 8,558,720 4.08%
Holding current value
$225 Million
Previous $239 Million 0.79%
% of portfolio
0.15%
Previous 0.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$27.7 - $31.39 $9.68 Million - $11 Million
-349,305 Reduced 4.08%
8,209,415 $238 Million
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $5.17 Million - $6.06 Million
-204,765 Reduced 2.34%
8,558,720 $239 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $24 Million - $27.5 Million
925,960 Added 11.81%
8,763,485 $243 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $20.2 Million - $26.2 Million
-771,857 Reduced 8.97%
7,837,525 $226 Million
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $4.33 Million - $5.06 Million
-135,019 Reduced 1.54%
8,609,382 $286 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $3.96 Million - $4.59 Million
-109,770 Reduced 1.24%
8,744,401 $321 Million
Q1 2023

Apr 14, 2023

BUY
$39.39 - $51.28 $12.3 Million - $16 Million
311,509 Added 3.65%
8,854,171 $361 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $14.6 Million - $19 Million
348,547 Added 4.25%
8,542,662 $438 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $7.19 Million - $8.77 Million
164,241 Added 2.05%
8,194,115 $359 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $3.45 Million - $4.09 Million
74,191 Added 0.93%
8,029,874 $421 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $24.9 Million - $30.8 Million
543,445 Added 7.33%
7,955,683 $412 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $6.27 Million - $9.29 Million
-151,716 Reduced 2.01%
7,412,238 $438 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $45 Million - $57.9 Million
-1,147,412 Reduced 13.17%
7,563,954 $325 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $20.1 Million - $22.7 Million
558,427 Added 6.85%
8,711,366 $341 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $22.1 Million - $24.9 Million
-660,488 Reduced 7.49%
8,152,939 $295 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $28.6 Million - $36.4 Million
-854,528 Reduced 8.84%
8,813,427 $324 Million
Q3 2020

Nov 04, 2020

SELL
$31.75 - $37.25 $25 Million - $29.3 Million
-786,766 Reduced 7.53%
9,667,955 $355 Million
Q2 2020

Jul 28, 2020

SELL
$30.12 - $36.54 $129 Million - $156 Million
-4,278,478 Reduced 29.04%
10,454,721 $342 Million
Q1 2020

Apr 21, 2020

BUY
$27.03 - $38.62 $8.84 Million - $12.6 Million
327,154 Added 2.27%
14,733,199 $481 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $60.5 Million - $68.6 Million
1,837,440 Added 14.62%
14,406,045 $564 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $64.3 Million - $83.4 Million
1,980,253 Added 18.7%
12,568,605 $452 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $28.5 Million - $32 Million
769,699 Added 7.84%
10,588,352 $459 Million
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $12.7 Million - $13.9 Million
-338,238 Reduced 3.33%
9,818,653 $417 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $28.3 Million - $32.2 Million
-734,402 Reduced 6.74%
10,156,891 $443 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $11.5 Million - $14 Million
334,410 Added 3.17%
10,891,293 $480 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $31 Million - $33.1 Million
940,153 Added 9.78%
10,556,883 $383 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $12.8 Million - $14.9 Million
401,662 Added 4.36%
9,616,730 $341 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $12.1 Million - $12.8 Million
363,546 Added 4.11%
9,215,068 $334 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $10.3 Million - $11.3 Million
331,993 Added 3.9%
8,851,522 $316 Million
Q2 2017

Aug 14, 2017

BUY
N/A
8,519,529
8,519,529 $286 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.